Read
- IRS official refuses to answer questions at scandal hearing
|
- Global stocks, oil fall after Bernanke; dollar gains
|
- Oklahoma tornado victims astounded at how they survived
|
- CORRECTED-White House threatens veto of bill to bypass Obama on Keystone
- FBI says man shot dead while being questioned about Boston bombings
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Message of humility
A religious fraternity in Rio considers the election of Pope Francis, a confirmation of their beliefs in poverty and simplicity. Slideshow
Sponsored Links
Roche looks to personalized medicine for growth
LONDON |
LONDON (Reuters) - Roche Holding AG, the world's biggest maker of cancer drugs, said it would build on its drive into personalized medicine to hold onto its long-term growth momentum and said it would keep up spending on research and development.
In a statement ahead of a presentation to investors in London on Wednesday, the Swiss drugmaker said it expected 19 late stage trials to read out over the next 18 months.
"More than 60 percent of our pharmaceutical pipeline projects are coupled with the development of companion diagnostics in order to make treatments more effective," Chief Executive Severin Schwan said in a statement.
Roche said it was committed to a stable R&D budget. It spent 8.3 billion Swiss francs ($8.71 billion)on R&D in 2011. The company is also targeting growth in emerging markets as austerity-hit European markets slash healthcare budgets.
(Reporting by Caroline Copley)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
This has been the dispute of Pharmaceutical Companies for years again Homeopathy, that because we treat our patients as individuals, that it is not possible for our medicines to fit into the current clinical trial models and thus it supposedly makes our medicine a farce.
So, someone please explain to me how they will possibly treat people individually and fit into the current models of scientific proof under the current system.



Follow Reuters